Clinical Trial: Survival Outcomes of Residual Disease in Triple-Negative Breast Cancer
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Triple-Negative Breast Cancer (TNBC)
Study Type: OBSERVATIONAL
Official Title: Survival Outcomes of Residual Disease in Patients With Triple-Negative Breast Cancer Following Neoadjuvant Therapy: A Retrospective Cohort Study
Brief Summary:
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with a poor prognosis. Although neoadjuvant therapy improves outcomes in patients who achieve a pathological complete response, the presence of residual disease after treatment remains associated with an increased risk of recurrence and death. This retrospective cohort study aims to evaluate the survival outcomes of patients with residual disease following neoadjuvant therapy for TNBC and to assess the association between…
Read more